Skip to main content
Top
Published in: BMC Complementary Medicine and Therapies 1/2016

Open Access 01-12-2015 | Research article

A survey of study participants’ understanding of informed consent to participate in a randomised controlled trial of acupuncture

Authors: Caroline A. Smith, Sarah Fogarty

Published in: BMC Complementary Medicine and Therapies | Issue 1/2016

Login to get access

Abstract

Background

It is important that potential study participants are appropriately informed and understand what is involved with their research participation. A few studies have examined study participants’ understanding of the informed consent process and the adequacy of the information they received when agreeing to participate in a randomised controlled trial. Deficiencies in the consent process have been found. This topic remains an under researched area of acupuncture research. The aim of this study was to examine participants’ understanding of their informed consent and the adequacy of the information presented when agreeing to participate in a randomised controlled trial of acupuncture.

Methods

All women who participated in a randomised controlled trial over an 11 month period were invited to participate in a survey. An anonymous self-completion questionnaire was designed and covered participants’ understanding of informed consent in the clinical trial, their views of the information provided, the opportunity to ask questions, the use of sham acupuncture, their recall of study visits and processes for withdrawal, and their reason for participating in the trial.

Results

A response rate of 59 % was obtained. Over 90 % of subjects indicated there was plenty of opportunity to discuss the study prior to giving consent, and 89 % indicated that questions asked were answered to their satisfaction. The majority of women indicated the amount of information describing acupuncture was about right, however 24 % would have liked more. Information describing sham acupuncture was not considered adequate by 48 % of women, and 35 % would have liked more information, 30 % could not recall why, or were uncertain why a sham group was used. Participants indicated less understanding of the information relating to payment if they became ill due to study participation, risks and discomforts from the study interventions, which of the procedures were experimental and for how long they would be involved in the study.

Conclusion

Trial participants’ understanding of informed consent was overall satisfactory but highlighted some areas of deficiency. Future studies could consider use of supplementary material such as Q and A fact sheets.
Literature
1.
go back to reference Ndebel P. The Declaration of Helsinki, 50 Years Later. J Am Med Assoc. 2013;310:2145–6.CrossRef Ndebel P. The Declaration of Helsinki, 50 Years Later. J Am Med Assoc. 2013;310:2145–6.CrossRef
2.
go back to reference Beauchamp TL, Childress JF. Principles of biomedical ethics. 5th ed. New York: Oxford University press; 2001. Beauchamp TL, Childress JF. Principles of biomedical ethics. 5th ed. New York: Oxford University press; 2001.
3.
go back to reference Brown R, Butow PN, Butt DG, Moore AR, Tattersall MH. Developing ethical strategies to assist oncologists in seeking informed consent to cancer clinical trials. Soc Sci Med. 2004;58:379–90.PubMedCrossRef Brown R, Butow PN, Butt DG, Moore AR, Tattersall MH. Developing ethical strategies to assist oncologists in seeking informed consent to cancer clinical trials. Soc Sci Med. 2004;58:379–90.PubMedCrossRef
4.
go back to reference Ellis PM, Dowsett SM, Butow PM, Tattersall MH. Attitudes to randomised clinical trials amongst out-patients attending a medical oncology clinic. Health Expect. 1999;2:33–43.PubMedCrossRef Ellis PM, Dowsett SM, Butow PM, Tattersall MH. Attitudes to randomised clinical trials amongst out-patients attending a medical oncology clinic. Health Expect. 1999;2:33–43.PubMedCrossRef
5.
go back to reference Sanchini V, Reni M, Calori G, Riva E, Reichin M. Informed consent as an ethical requirement in clinical trials: an old, but still unresolved issue. An observational study to evaluate patient's informed consent comprehension. J Med Ethics. 2014;40(4):269–75.PubMedCrossRef Sanchini V, Reni M, Calori G, Riva E, Reichin M. Informed consent as an ethical requirement in clinical trials: an old, but still unresolved issue. An observational study to evaluate patient's informed consent comprehension. J Med Ethics. 2014;40(4):269–75.PubMedCrossRef
6.
go back to reference Hughes G, Russell W, Breckons M, Richardson J, Llyod-Williams M, Molassiotis A. “I assumed that one was a placebo”: exploring the consent process in a sham controlled acupressure trial. Complemnt Ther Med. 2014;22:903–8.CrossRef Hughes G, Russell W, Breckons M, Richardson J, Llyod-Williams M, Molassiotis A. “I assumed that one was a placebo”: exploring the consent process in a sham controlled acupressure trial. Complemnt Ther Med. 2014;22:903–8.CrossRef
7.
go back to reference Smith CA, de Lacey S, Chapman C, Ratcliffe, Norman R, Johnson N, Sacks G, Lyttleton J, Boothroyd C: Acupuncture to improve live birth rates for women undergoing in vitro fertilisation a protocol for a randomised controlled trial. Trials 2012, 13(60). doi:10.1186/1745-6215-13-60. Smith CA, de Lacey S, Chapman C, Ratcliffe, Norman R, Johnson N, Sacks G, Lyttleton J, Boothroyd C: Acupuncture to improve live birth rates for women undergoing in vitro fertilisation a protocol for a randomised controlled trial. Trials 2012, 13(60). doi:10.​1186/​1745-6215-13-60.
8.
go back to reference Park J, White A, Stevinson C, et al. Validating a new non-penetrating sham acupuncture device: two randomised controlled trials. Acupunct Med. 2002;20:168–74.PubMedCrossRef Park J, White A, Stevinson C, et al. Validating a new non-penetrating sham acupuncture device: two randomised controlled trials. Acupunct Med. 2002;20:168–74.PubMedCrossRef
9.
go back to reference Behrendt C, Golz T, Roesler C, Bertz H, Wunsch A. What do our patients understand about their trial participation? Assessing patient's understanding of their informed consent consultation about randomised controlled trial. J Med Ethics. 2011;37:74–80.PubMedCrossRef Behrendt C, Golz T, Roesler C, Bertz H, Wunsch A. What do our patients understand about their trial participation? Assessing patient's understanding of their informed consent consultation about randomised controlled trial. J Med Ethics. 2011;37:74–80.PubMedCrossRef
11.
go back to reference Joffe S, Cook EF, Cleary PD, Clark JW, Weeks JC. Quality of Informed Consent: a New Measure of Understanding Among Research Subjects. J Natl Cancer Inst. 2001;93(2):139–47.PubMedCrossRef Joffe S, Cook EF, Cleary PD, Clark JW, Weeks JC. Quality of Informed Consent: a New Measure of Understanding Among Research Subjects. J Natl Cancer Inst. 2001;93(2):139–47.PubMedCrossRef
12.
go back to reference Joffe S, Cook FE, Cleary PD, Clark JW, Weeks JC. Quality of informed consent in cancer clinical trials: a cross sectional survey. Lancet. 2001;358:1772–7.PubMedCrossRef Joffe S, Cook FE, Cleary PD, Clark JW, Weeks JC. Quality of informed consent in cancer clinical trials: a cross sectional survey. Lancet. 2001;358:1772–7.PubMedCrossRef
13.
go back to reference Falagas ME, Korbila IP, Giannopoulou KP, et al. Informed consent: how much and what do patients understand? Am J Surg. 2009;198:420–35.PubMedCrossRef Falagas ME, Korbila IP, Giannopoulou KP, et al. Informed consent: how much and what do patients understand? Am J Surg. 2009;198:420–35.PubMedCrossRef
14.
go back to reference Kodish E, Eder M, Noll RB, Ruccione K, Lange B, Angiolillo A, et al. Communication of randomization in childhood leukemia trials. JAMA. 2004;291(4):470–5.PubMedCrossRef Kodish E, Eder M, Noll RB, Ruccione K, Lange B, Angiolillo A, et al. Communication of randomization in childhood leukemia trials. JAMA. 2004;291(4):470–5.PubMedCrossRef
15.
go back to reference Snowden C, Garcia J, Elbourne D. Making sense of randomisation: responses of parents of critically ill babies to random allocation of treatment in a clinical trial. Soc Sci Med. 1997;45(9):1337–55.CrossRef Snowden C, Garcia J, Elbourne D. Making sense of randomisation: responses of parents of critically ill babies to random allocation of treatment in a clinical trial. Soc Sci Med. 1997;45(9):1337–55.CrossRef
16.
go back to reference Kass NE, Taylor HA, Ali J, Hallez K, Chaisson L: A pilot study of simple interventions to improve informed consent in clinical research: feasibility, approach and results. Clin Trials 2014, Dec 4. pii: 1740774514560831. [Epub ahead of print]. Kass NE, Taylor HA, Ali J, Hallez K, Chaisson L: A pilot study of simple interventions to improve informed consent in clinical research: feasibility, approach and results. Clin Trials 2014, Dec 4. pii: 1740774514560831. [Epub ahead of print].
17.
go back to reference Nishimura A, Carey J, Erwin PJ, Tilburt JC, Murad MH, McCormick JB. Improving understanding in the research informed consent process: a systematic review of 54 interventions tested in randomized control trials. BMC Med Ethics. 2013;14:28.PubMedPubMedCentralCrossRef Nishimura A, Carey J, Erwin PJ, Tilburt JC, Murad MH, McCormick JB. Improving understanding in the research informed consent process: a systematic review of 54 interventions tested in randomized control trials. BMC Med Ethics. 2013;14:28.PubMedPubMedCentralCrossRef
Metadata
Title
A survey of study participants’ understanding of informed consent to participate in a randomised controlled trial of acupuncture
Authors
Caroline A. Smith
Sarah Fogarty
Publication date
01-12-2015
Publisher
BioMed Central
Published in
BMC Complementary Medicine and Therapies / Issue 1/2016
Electronic ISSN: 2662-7671
DOI
https://doi.org/10.1186/s12906-015-0975-y

Other articles of this Issue 1/2016

BMC Complementary Medicine and Therapies 1/2016 Go to the issue